Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Valérie De Haas"'
Autor:
Lili Kotmayer, Emilia Kozyra, Maximilian Kaiser, Michael Dworzak, Barbara De Moerloose, Jan Starý, Henrik Hasle, Kirsi Jahnukainen, Sophia Polychronopoulou, Krisztián Kállay, Owen Smith, Shlomit Barzilai, Riccardo Masetti, Jochen Buechner, Marek Ussowicz, Paula Kjollerstrom, Ivana Boďová, Marko Kavcic, Albert Catala, Dominik Turkiewicz, Markus Schmugge, Valérie De Haas, Rebecca Voss, Anna Bigas, Damia Romero, Csaba Bödör, Miriam Erlacher, Alessandra Giorgetti, Charlotte Niemeyer, Marcin Wlodarski
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100051- (2023)
Externí odkaz:
https://doaj.org/article/c011b85abdfb4cc3bb60ff8c8419145c
Autor:
Ayami Yoshimi, Miriam Erlacher, Peter Noellke, Senthilkumar Ramamoorthy, Gudrun Göhring, Shlomit Barzilai – Birenboim, Ivana Bodova, Jochen Buechner, Albert Catala, Valérie De Haas, Barbara De Moerloose, Michael Dworzak, Henrik Hasle, Kirsi Jahnukainen, Krisztian Kallay, Marko Kavcic, Paula Kjollerstrom, Franco Locatelli, Riccardo Masetti, Sophia Polychronopoulou, Markus Schmugge, Owen Smith, Jan Stary, Dominik Turkiewicz, Marek Ussowicz, Natalia Rotari, Marcin Wlodarski, Brigitte Strahm, Charlotte Niemeyer
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100071- (2023)
Externí odkaz:
https://doaj.org/article/cf18133fdb9d41dabaf3d41295f0b02d
Autor:
Sebastiaan D.T. Sassen, Ron A.A. Mathôt, Rob Pieters, Robin Q.H. Kloos, Valérie de Haas, Gertjan J.L. Kaspers, Cor van den Bos, Wim J.E. Tissing, Maroeska te Loo, Marc B. Bierings, Wouter J.W. Kollen, Christian M. Zwaan, Inge M. van der Sluis
Publikováno v:
Haematologica, Vol 102, Iss 3 (2017)
Erwinia asparaginase is an important component in the treatment of pediatric acute lymphoblastic leukemia. A large variability in serum concentrations has been observed after intravenous Erwinia asparaginase. Currently, Dutch Childhood Oncology Group
Externí odkaz:
https://doaj.org/article/2272e63ed0f845619d1af21e29d1e8da
Autor:
Costa Bachas, Gerrit Jan Schuurhuis, C Michel Zwaan, Marry M van den Heuvel-Eibrink, Monique L den Boer, Eveline S J M de Bont, Zinia J Kwidama, Dirk Reinhardt, Ursula Creutzig, Valérie de Haas, Gertjan J L Kaspers, Jacqueline Cloos
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0121730 (2015)
Development of relapse remains a problem for further improvements in the survival of pediatric AML patients. While virtually all patients show a good response to initial treatment, more patients respond poorly when treated at relapse. The cellular ch
Externí odkaz:
https://doaj.org/article/f2c2fd5f271c447aa5b3df572240735c
Autor:
Julie Damgaard Sandahl, Eva A. Coenen, Erik Forestier, Jochen Harbott, Bertil Johansson, Gitte Kerndrup, Souichi Adachi, Anne Auvrignon, H. Berna Beverloo, Jean-Michel Cayuela, Lucy Chilton, Maarten Fornerod, Valérie de Haas, Christine J. Harrison, Hiroto Inaba, Gertjan J.L. Kaspers, Der-Cherng Liang, Franco Locatelli, Riccardo Masetti, Christine Perot, Susana C. Raimondi, Katarina Reinhardt, Daisuke Tomizawa, Nils von Neuhoff, Marco Zecca, C. Michel Zwaan, Marry M. van den Heuvel-Eibrink, Henrik Hasle
Publikováno v:
Haematologica, Vol 99, Iss 5 (2014)
Acute myeloid leukemia with t(6;9)(p22;q34) is listed as a distinct entity in the 2008 World Health Organization classification, but little is known about the clinical implications of t(6;9)-positive myeloid leukemia in children. This international m
Externí odkaz:
https://doaj.org/article/c2981595332d4bc2ba894d8103bc04b6
Autor:
David G J, Cucchi, Barbara, Denys, Gertjan J L, Kaspers, Jeroen J W M, Janssen, Gert J, Ossenkoppele, Valérie, de Haas, C Michel, Zwaan, Marry M, van den Heuvel-Eibrink, Jan, Philippé, Tamás, Csikós, Zinia, Kwidama, Barbara, de Moerloose, Eveline S J M, de Bont, Birgit I, Lissenberg-Witte, Sonja, Zweegman, Femke, Verwer, Karl, Vandepoele, Gerrit Jan, Schuurhuis, Edwin, Sonneveld, Jacqueline, Cloos
Publikováno v:
Blood. 131(22)
Controversy exists whether internal tandem duplication of FMS-like tyrosine kinase 3 (
Autor:
Janine Stutterheim, Rachella Van der Waarden, Hester de Groot-Kruseman, Edwin Sonneveld, Valerie De Haas, Ellen C Van der Schoot, Vincent van der Velden, Rana Dandis, Rob Pieters
Publikováno v:
HemaSphere, Vol 7, p e07648d1 (2023)
Externí odkaz:
https://doaj.org/article/cd45ceb2d964436eb7d18ad6e0524ee0
Autor:
Irith, Baumann, Monika, Führer, Sonja, Behrendt, Vit, Campr, Judit, Csomor, Ingrid, Furlan, Valérie, de Haas, Gitte, Kerndrup, Roos J, Leguit, Pascale, De Paepe, Peter, Noellke, Charlotte, Niemeyer, Stephan, Schwarz
Publikováno v:
Histopathology. 61(1)
To evaluate the reproducibility and reliability of the histomorphological criteria differentiating severe aplastic anaemia (SAA) and hypoplastic refractory cytopenia of childhood (RCC), the most frequently acquired hypocellular bone marrow conditions
Autor:
Ilse M G, Hageman, Annemarie M L, Peek, Valérie, de Haas, Carin M, Damen-Korbijn, Gertjan J L, Kaspers
Publikováno v:
Pediatric bloodcancer. 59(7)
The outcome of the treatment of pediatric acute myeloid leukemia (AML) is still disappointing, due to relatively high treatment-related mortality and relapse rates (30-40%). Past treatment protocols have called for routine screening via bone marrow a
Autor:
Dominique Couanet, Valérie de Haas, Jacques Grill, Christian Sainte-Rose, Véronique Laithier, Chantal Kalifa, Virginie Kieffer, Jean-Louis Habrand, Marie-Anne Raquin
Publikováno v:
Pediatric Blood and Cancer, 52(5), 575-580. Wiley-Liss Inc.
de Haas, V, Grill, J, Raquin, M A, Couanet, D, Habrand, J L, Sainte-Rose, C, Laithier, V, Kieffer, V & Kalifa, C 2009, ' Relapses of Optic Pathway Tumors After First-Line Chemotherapy ', Pediatric Blood and Cancer, vol. 52, no. 5, pp. 575-580 . https://doi.org/10.1002/pbc.21911
de Haas, V, Grill, J, Raquin, M A, Couanet, D, Habrand, J L, Sainte-Rose, C, Laithier, V, Kieffer, V & Kalifa, C 2009, ' Relapses of Optic Pathway Tumors After First-Line Chemotherapy ', Pediatric Blood and Cancer, vol. 52, no. 5, pp. 575-580 . https://doi.org/10.1002/pbc.21911
Background Chemotherapy is accepted as first-line conservative treatment of optic pathway tumors in patients younger than 5. Limited data are available on the outcome of patients with recurrence/progression after initial chemotherapy. Procedure Data